0 513

Cited 9 times in

Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B

DC Field Value Language
dc.contributor.author김범석-
dc.contributor.author김승업-
dc.contributor.author김형우-
dc.contributor.author안상훈-
dc.contributor.author정찬영-
dc.date.accessioned2022-05-09T17:22:12Z-
dc.date.available2022-05-09T17:22:12Z-
dc.date.issued2022-04-
dc.identifier.issn1542-3565-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188529-
dc.description.abstractOf the antiviral agents currently available to patients with chronic hepatitis B (CHB), entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are 2 of 3 first-line agents.1-3 Given the well-known renal and bone toxicity associated with TDF,4 major international hepatitis B virus treatment guidelines recommend ETV over TDF in patients with predisposing factors to kidney function decline.1-3 However, as evidenced by recent studies, nephrotoxicity of antiviral agents is still an issue under debate.5-7 Therefore, we investigated the differences in the risk of kidney function decline in patients with treatment-naive CHB who were treated with ETV or TDF.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherW.B. Saunders-
dc.relation.isPartOfCLINICAL GASTROENTEROLOGY AND HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntiviral Agents / adverse effects-
dc.subject.MESHGuanine / adverse effects-
dc.subject.MESHGuanine / analogs & derivatives-
dc.subject.MESHHepatitis B virus-
dc.subject.MESHHepatitis B, Chronic* / drug therapy-
dc.subject.MESHHumans-
dc.subject.MESHKidney-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTenofovir / adverse effects-
dc.subject.MESHTreatment Outcome-
dc.titleTenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorChan-Young Jung-
dc.contributor.googleauthorHyung Woo Kim-
dc.contributor.googleauthorSang Hoon Ahn-
dc.contributor.googleauthorSeung Up Kim-
dc.contributor.googleauthorBeom Seok Kim-
dc.identifier.doi10.1016/j.cgh.2021.05.032-
dc.contributor.localIdA00488-
dc.contributor.localIdA00654-
dc.contributor.localIdA01151-
dc.contributor.localIdA02226-
dc.contributor.localIdA06058-
dc.relation.journalcodeJ02981-
dc.identifier.eissn1542-7714-
dc.identifier.pmid34029751-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S154235652100570X-
dc.contributor.alternativeNameKim, Beom Seok-
dc.contributor.affiliatedAuthor김범석-
dc.contributor.affiliatedAuthor김승업-
dc.contributor.affiliatedAuthor김형우-
dc.contributor.affiliatedAuthor안상훈-
dc.contributor.affiliatedAuthor정찬영-
dc.citation.volume20-
dc.citation.number4-
dc.citation.startPage956-
dc.citation.endPage958.e2-
dc.identifier.bibliographicCitationCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, Vol.20(4) : 956-958.e2, 2022-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.